Chemist + Druggist: A New Generation Of Drug

Chemist + Druggist logo

Originally published in Chemist + Druggist, 3rd September 2014

By Annabelle Collins

Pressure is growing for the government to legalise and fund the use of medicinal cannabis. So how likely is it that cannabis-based medicines will become commonplace in UK dispensaries?

A few years ago, the idea of dispensing cannabis on the NHS seemed unthinkable. Although the pain-relieving properties of the class B drug have long been recognised, its use is banned even for medicinal purposes. But there is increasing pressure for the NHS to fund the new generation of cannabis-based medicines, which claims to have maximum patient benefits and minimal side effects.

The move seemed to gain ground last month, when Wales approved one of these medicines - Sativex - for use in multiple sclerosis (MS). The drug's...

Rate this article: 

This marijuana news is brought to you by 420 Intel. For the latest breaking cannabis industry news, subscribe to the 420 Intel newsletter. If you'd like to promote your product or service in this area after every article, contact us.